Office Hours: Cholesterol and Heart Disease — What I’ve Changed My Mind About

Key Takeaways Copied to clipboard!

• Heart disease is primarily a metabolic and inflammatory disease, not solely driven by high LDL cholesterol, as evidenced by half of heart attack victims having normal LDL levels.  Copied to clipboard!
• The standard cholesterol test is often the wrong metric; the number and quality of cholesterol particles (measured by ApoB and lipoprotein fractionation) and markers of inflammation (like HSCRP) are far more predictive of cardiovascular risk.  Copied to clipboard!
• Sugar and refined starches, which drive insulin resistance and inflammation, are the main culprits behind the heart disease epidemic, not dietary fat intake for the majority of the population.  Copied to clipboard!

Segments Expand All Collapse All

Introduction and Evolving Science

Copied to clipboard!

(00:00:12)

• Key Takeaway: Scientific understanding evolves, necessitating changes in medical practice, exemplified by the outdated belief that low-fat diets prevent heart disease.
• Summary: Dr. Hyman emphasizes that science is an evolving process, requiring practitioners to update their thinking when old ideas, like the universal benefit of low-fat diets, are disproven by data. He notes that the low-fat movement inadvertently led to increased obesity and diabetes. This episode focuses on what he has changed his mind about regarding cholesterol and heart disease.

Flaws in Standard Cholesterol Testing

Copied to clipboard!

(00:01:59)

• Key Takeaway: Standard LDL cholesterol tests are inadequate predictors of heart attacks, as up to 75% of heart attack patients have ’normal’ LDL levels.
• Summary: The traditional approach of lowering LDL cholesterol at all costs is outdated because it ignores the underlying causes of heart disease. Most doctors order the wrong cholesterol test, focusing only on weight rather than particle quality and number. Function Health emphasizes testing markers like ApoB, which is considered far more important than standard LDL measurements.

Inflammation as the True Driver

Copied to clipboard!

(00:05:28)

• Key Takeaway: Inflammation, identified as a key driver of heart disease, is often a more significant risk factor than cholesterol levels alone.
• Summary: Seminal research indicates that inflammation causes cholesterol to become deposited in the arteries, leading to plaque formation. High-sensitivity C-reactive protein (HSCRP) may be more important than LDL in predicting heart disease risk. Cholesterol only becomes dangerous when it is oxidized or ‘rancid’ due to underlying inflammation.

Metabolic Dysfunction and Atherogenic Dyslipidemia

Copied to clipboard!

(00:06:46)

• Key Takeaway: For most people, heart disease stems from metabolic dysfunction, specifically insulin resistance driven by high sugar and starch intake.
• Summary: Insulin resistance causes atherogenic dyslipidemia, characterized by the formation of small, dense cholesterol particles that damage artery linings. The primary driver of this process is the consumption of sugar and starch, which leads to inflammation and visceral fat accumulation. This metabolic issue affects nearly 93% of the American population.

Key Predictive Biomarkers

Copied to clipboard!

(00:09:10)

• Key Takeaway: Apolipoprotein B (ApoB) is the most reliable marker for heart attack risk, serving as a surrogate for poor metabolic health, and should be tracked alongside Lipoprotein(a) and the Triglyceride-to-HDL ratio.
• Summary: ApoB reflects the total number of damaging cholesterol particles and is now recognized by cardiology guidelines as a causal factor in heart disease. Lipoprotein(a) is a highly important, genetically determined risk factor that requires managing all other metabolic factors if elevated. The triglyceride-to-HDL ratio is a simple, effective measure of insulin resistance.

Dietary Fat vs. Sugar Danger

Copied to clipboard!

(00:08:28)

• Key Takeaway: Sugar, not dietary fat, is the primary cause of heart attacks for the majority of the population, as it drives the underlying metabolic dysfunction.
• Summary: Large studies confirm that dietary saturated fat is not the primary driver of heart disease; trans fats are dangerous, but refined starches and sugar are far more harmful. Treating sugar as a recreational drug is recommended due to its role in driving inflammation and insulin resistance. While individual responses vary, reducing sugar and starch intake is crucial for correcting the metabolic imbalance.

TOFI and Metabolic Health Testing

Copied to clipboard!

(00:20:31)

• Key Takeaway: Metabolic dysfunction, indicated by insulin resistance, significantly increases heart disease risk (fourfold) independent of LDL, affecting even normal-weight individuals (TOFI).
• Summary: Thin On the Outside, Fat On the Inside (TOFI) individuals can have normal weight but possess high visceral fat and insulin resistance, carrying the same heart disease risk as obesity. Doctors rarely check critical metabolic markers like fasting insulin, which is essential for understanding longevity risk. Continuous glucose monitors offer dynamic insight into how specific foods affect an individual’s blood sugar response.

Actionable Steps for Heart Health

Copied to clipboard!

(00:22:08)

• Key Takeaway: Managing heart health requires getting the right tests (ApoB, Lp(a), HSCRP, fasting insulin), adopting an anti-inflammatory, low-glycemic diet, and prioritizing lifestyle factors like exercise.
• Summary: Listeners must test, not guess, by obtaining comprehensive labs like ApoB and a calcium score to assess actual plaque development, as cholesterol numbers alone are insufficient. Dietary focus should be on cutting sugar and refined starches while increasing whole, anti-inflammatory foods and omega-3 fats. Lifestyle interventions, including exercise (especially strength training), stress management, and sleep, are critical for correcting insulin resistance and lowering APOB.